{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:14:19Z","timestamp":1788437659043,"version":"build-2803163510"},"reference-count":86,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020889","name":"Tehran University of Medical Sciences Endocrinology and Metabolism Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020889","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.dsx.2024.103083","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T19:29:03Z","timestamp":1721503743000},"page":"103083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comprehensive investigation of insulin-induced amyloidosis lesions in patients with diabetes at clinical and histological levels: A systematic review"],"prefix":"10.1016","volume":"18","author":[{"given":"Leyla","family":"Karkhaneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Hosseinkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Azami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalda","family":"Karamlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sheidaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ensieh","family":"Nasli-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Razi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-4859","authenticated-orcid":false,"given":"Azadeh","family":"Ebrahim-Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dsx.2024.103083_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/dmrr.931","article-title":"Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy","volume":"25","author":"Bruttomesso","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 2","key":"10.1016\/j.dsx.2024.103083_bib2","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.2337\/dc11-s225","article-title":"Insulin: potential negative consequences of early routine use in patients with type 2 diabetes","volume":"34","author":"Lebovitz","year":"2011","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.dsx.2024.103083_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00128071-200304100-00001","article-title":"Skin-related complications of insulin therapy: epidemiology and emerging management strategies","volume":"4","author":"Richardson","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/2230-8210.146879","article-title":"Insulin-derived amyloidosis","volume":"19","author":"Gupta","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib5","first-page":"108","article-title":"Iatrogenic, insulin-dependent, local amyloidosis","volume":"48","author":"St\u00f6rkel","year":"1983","journal-title":"Lab Invest"},{"issue":"10","key":"10.1016\/j.dsx.2024.103083_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/cup.14087","article-title":"Insulin-induced amyloidosis in a diabetic patient","volume":"49","author":"Aghighi","year":"2022","journal-title":"J Cutan Pathol"},{"issue":"10","key":"10.1016\/j.dsx.2024.103083_bib7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.prp.2017.08.013","article-title":"Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis","volume":"213","author":"Ansari","year":"2017","journal-title":"Pathol Res Pract"},{"issue":"7","key":"10.1016\/j.dsx.2024.103083_bib8","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1016\/j.dsx.2024.103083_bib9","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1021\/bi002555c","article-title":"Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism","volume":"40","author":"Nielsen","year":"2001","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.dsx.2024.103083_bib10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.xphs.2016.01.003","article-title":"Structure, aggregation, and activity of a covalent insulin dimer formed during storage of neutral formulation of human insulin","volume":"105","author":"Hjorth","year":"2016","journal-title":"J Pharmaceut Sci"},{"issue":"45","key":"10.1016\/j.dsx.2024.103083_bib11","doi-asserted-by":"crossref","first-page":"18990","DOI":"10.1073\/pnas.0910080106","article-title":"Molecular basis for insulin fibril assembly","volume":"106","author":"Ivanova","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.dsx.2024.103083_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2012.05.133","article-title":"Dissecting the role of disulfide bonds on the amyloid formation of insulin","volume":"423","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.dsx.2024.103083_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjmed.2013.10.029","article-title":"Insulin-derived amyloidosis and poor glycemic control: a case series","volume":"127","author":"Nagase","year":"2014","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.dsx.2024.103083_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3892\/etm.2014.1772","article-title":"Generating local amyloidosis in mice by the subcutaneous injection of human insulin amyloid fibrils","volume":"8","author":"Chinisaz","year":"2014","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/db18-0846","article-title":"Extreme adhesion activity of amyloid fibrils induces subcutaneous insulin resistance","volume":"68","author":"Nakamura","year":"2019","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.dsx.2024.103083_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2169\/internalmedicine.49.2633","article-title":"Localized amyloidosis at the site of repeated insulin injection in a diabetic patient","volume":"49","author":"Shikama","year":"2010","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.diabres.2006.07.013","article-title":"Severe insulin resistance associated with subcutaneous amyloid deposition","volume":"75","author":"Albert","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13506129.2016.1179183","article-title":"Insulin amyloid at injection sites of patients with diabetes","volume":"23","author":"Nilsson","year":"2016","journal-title":"Amyloid"},{"issue":"7","key":"10.1016\/j.dsx.2024.103083_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/cup.12501","article-title":"Nodular amyloidosis at the sites of insulin injections","volume":"42","author":"Bern\u00e1rdez","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103083_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/cup.13613","article-title":"An abdominal wall mass of exogenous insulin amyloidosis in setting of metastatic sarcoma","volume":"47","author":"Carll","year":"2020","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/ced.14097","article-title":"Atypical presentation of localized insulin-derived amyloidosis as protruding brownish skin tumours","volume":"45","author":"Chen","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex differences in metabolic regulation and diabetes susceptibility","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.dsx.2024.103083_bib22","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/j.jaad.2014.07.017","article-title":"Localized insulin-dependent amyloidosis with scar-tissue formation","volume":"71","author":"Damm","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103083_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00256-020-03560-3","article-title":"Amyloidoma: a review and case report","volume":"50","author":"Desai","year":"2021","journal-title":"Skeletal Radiol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF00276849","article-title":"Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient","volume":"31","author":"Dische","year":"1988","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.dsx.2024.103083_bib55","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1002\/ajh.23334","article-title":"Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate","volume":"87","author":"D'Souza","year":"2012","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103083_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/13506129.2013.876984","article-title":"Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration","volume":"21","author":"D'Souza","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.dsx.2024.103083_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1064832","article-title":"Insulin amyloidosis: a case report","volume":"10","author":"Dubernet","year":"2023","journal-title":"Front Med"},{"issue":"6","key":"10.1016\/j.dsx.2024.103083_bib56","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.jaad.2010.03.001","article-title":"Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation","volume":"63","author":"Endo","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2337\/cd21-0118","article-title":"Impact of insulin-derived amyloidosis on glycemic control and insulin dosing","volume":"40","author":"Estep","year":"2022","journal-title":"Clin Diabetes"},{"issue":"12","key":"10.1016\/j.dsx.2024.103083_bib45","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/DAD.0000000000002314","article-title":"Two cases of insulin-derived amyloidosis with acanthosis nigricans-like changes","volume":"44","author":"Godse","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.dsx.2024.103083_bib52","first-page":"15","article-title":"Amyloidoma secondary to insulin injection: cytologic diagnosis and pitfalls","volume":"12","author":"Grunes","year":"2015","journal-title":"CytoJournal"},{"key":"10.1016\/j.dsx.2024.103083_bib24","article-title":"Localized subcutaneous insulin-derived amyloidosis excised after evaluation using ultrasonography in a patient with type 2 diabetes mellitus","volume":"2017","author":"Hagiwara","year":"2017","journal-title":"Case Rep Endocrinol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/13506129.2022.2047019","article-title":"A case of asymmetric insulin-derived localised amyloid deposition associated with long-acting insulin analog administration","volume":"29","author":"Hirai","year":"2022","journal-title":"Amyloid"},{"issue":"8","key":"10.1016\/j.dsx.2024.103083_bib40","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1111\/j.1365-2230.2009.03711.x","article-title":"Localized cutaneous amyloid at an insulin injection site","volume":"34","author":"Lonsdale-Eccles","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12902-019-0385-0","article-title":"Toxicity of insulin-derived amyloidosis: a case report","volume":"19","author":"Iwaya","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.16726","article-title":"Image Gallery: amyloidoma secondary to insulin injection","volume":"179","author":"John","year":"2018","journal-title":"Br J Dermatol"},{"issue":"47","key":"10.1016\/j.dsx.2024.103083_bib30","article-title":"Insulin-derived amyloidosis","volume":"194","author":"Kano","year":"2022","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"7","key":"10.1016\/j.dsx.2024.103083_bib47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/DAD.0000000000001052","article-title":"New histologic finding of amyloid insulin bodies at an insulin injection site in a patient with diabetes","volume":"40","author":"Katzman","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib33","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.12788\/cutis.0161","article-title":"Cutaneous insulin-derived amyloidosis presenting as hyperkeratotic nodules","volume":"107","author":"Kranc","year":"2021","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2230.2012.04373.x","article-title":"Coexistence of insulin-derived amyloidosis and an overlying acanthosis nigricans-like lesion at the site of insulin injection","volume":"38","author":"Kudo-Watanuki","year":"2013","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.dsx.2024.103083_bib25","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/dme.13137","article-title":"Localized insulin amyloidosis with use of concentrated insulin: a potential complication","volume":"33","author":"Mangla","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2024.103083_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-219491","article-title":"Isolated insulin-derived amyloidoma of the breast","volume":"2017","author":"Mayhew","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.dsx.2024.103083_bib34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/jdi.13199","article-title":"Insulin-derived amyloidosis without a palpable mass at the insulin injection site: a report of two cases","volume":"11","author":"Nagase","year":"2020","journal-title":"J Diabetes Investig."},{"issue":"sup1","key":"10.1016\/j.dsx.2024.103083_bib57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13506129.2019.1582517","article-title":"Clinical and MRI characteristics and follow-up studies of insulin-derived amyloidosis","volume":"26","author":"Nagase","year":"2019","journal-title":"Amyloid"},{"issue":"9658","key":"10.1016\/j.dsx.2024.103083_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0140-6736(09)60041-6","article-title":"The insulin ball","volume":"373","author":"Nagase","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0377-4929.130920","article-title":"Cutaneous amyloidosis and insulin with coexistence of acanthosis nigricans","volume":"57","author":"Nandeesh","year":"2014","journal-title":"Indian J Pathol Microbiol"},{"issue":"12","key":"10.1016\/j.dsx.2024.103083_bib36","doi-asserted-by":"crossref","DOI":"10.2337\/dc13-1651","article-title":"Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes","volume":"36","author":"Okamura","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2024.103083_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/dc.10296","article-title":"Amyloid tumor: a clinical and cytomorphologic study","volume":"28","author":"Sahoo","year":"2003","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103083_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jdcr.2020.02.011","article-title":"Insulin-derived amyloidosis: the insulin ball, amyloidoma","volume":"6","author":"Samlaska","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/23320885.2016.1247650","article-title":"Progressive insulin-derived amyloidosis in a patient with type 2 diabetes","volume":"3","author":"Shiba","year":"2016","journal-title":"Case Reports Plast Surg Hand Surg."},{"key":"10.1016\/j.dsx.2024.103083_bib78","first-page":"124","article-title":"Localised amyloid at injection sites derived from porcine and human insulin","volume":"17","author":"Gilbertson","year":"2010","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4158\/EP171865.CR","article-title":"An atypical presentation of insulin amyloidosis: an uncommon but important complication of insulin therapy","volume":"4","author":"Sullivan","year":"2018","journal-title":"AACE Clinical Case Reports"},{"issue":"10","key":"10.1016\/j.dsx.2024.103083_bib27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1046\/j.1464-5491.2002.07581.x","article-title":"Examination of insulin injection sites: an unexpected finding of localized amyloidosis","volume":"19","author":"Swift","year":"2002","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/dc.24616","article-title":"Insulin-induced amyloidoma-A cytological catch","volume":"49","author":"Tummidi","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.dsx.2024.103083_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jdcr.2021.11.003","article-title":"Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection","volume":"19","author":"Vuillamy","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"11","key":"10.1016\/j.dsx.2024.103083_bib42","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.humpath.2009.02.019","article-title":"Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report","volume":"40","author":"Yumlu","year":"2009","journal-title":"Hum Pathol"},{"issue":"1149","key":"10.1016\/j.dsx.2024.103083_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/postgradmedj-2020-138428","article-title":"Cutaneous amyloidoma secondary to repeated insulin injections","volume":"97","author":"Ip","year":"2021","journal-title":"Postgrad Med"},{"issue":"8","key":"10.1016\/j.dsx.2024.103083_bib44","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1089\/ars.2012.4931","article-title":"Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities","volume":"20","author":"Singh","year":"2014","journal-title":"Antioxidants Redox Signal"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00256-017-2749-8","article-title":"Imaging characteristics of subcutaneous amyloid deposits in diabetic patients: the \"insulin ball\"","volume":"47","author":"Tanio","year":"2018","journal-title":"Skeletal Radiol"},{"issue":"12","key":"10.1016\/j.dsx.2024.103083_bib59","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.ultrasmedbio.2018.08.010","article-title":"Ultrasonography improves glycemic control by detecting insulin-derived localized amyloidosis","volume":"44","author":"Kikuchi","year":"2018","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib60","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diacare.25.3.634","article-title":"Lipohypertrophy in young patients with type 1 diabetes","volume":"25","author":"Kordonouri","year":"2002","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.dsx.2024.103083_bib61","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/diacare.28.8.2025","article-title":"Impaired absorption of insulin aspart from lipohypertrophic injection sites","volume":"28","author":"Johansson","year":"2005","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2024.103083_bib62","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4103\/2230-8210.113788","article-title":"Insulin lipodystrophy and lipohypertrophy","volume":"17","author":"Mokta","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2024.103083_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4910962","article-title":"Effect of insulin-induced lipodystrophy on glycemic control among children and adolescents with diabetes in tikur anbessa specialized hospital, addis ababa, Ethiopia","volume":"2018","author":"Tsadik","year":"2018","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib64","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.diabres.2007.12.026","article-title":"A case of lipoatrophy with insulin detemir","volume":"80","author":"Del Olmo","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1507\/endocrj.K06-173","article-title":"A case of insulin-induced localized lobular panniculitis with evidence for the phagocytosis of insulin by histiocytes","volume":"54","author":"Shimizu","year":"2007","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib66","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/dc07-1739","article-title":"Human insulin analog--induced lipoatrophy","volume":"31","author":"Lopez","year":"2008","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.dsx.2024.103083_bib67","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s001250051476","article-title":"\"Lipoblastoma-like\" lipoatrophy induced by human insulin: morphological evidence for local dedifferentiation of adipocytes?","volume":"43","author":"Jermendy","year":"2000","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00128071-200708010-00003","article-title":"Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs","volume":"8","author":"Radermecker","year":"2007","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103083_bib69","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.diabres.2011.07.023","article-title":"Acanthosis nigricans as a local cutaneous side effect of repeated human insulin injections","volume":"94","author":"Buz\u00e1si","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5070\/D31W06W6RG","article-title":"Exogenous insulin-derived acanthosis nigricans: could it be a cause of increased insulin requirement?","volume":"19","author":"Dhingra","year":"2013","journal-title":"Dermatol Online J"},{"issue":"7","key":"10.1016\/j.dsx.2024.103083_bib71","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jbm.a.37097","article-title":"Advancing continuous subcutaneous insulin infusion in vivo: new insights into tissue challenges","volume":"109","author":"Kesserwan","year":"2021","journal-title":"J Biomed Mater Res"},{"issue":"6","key":"10.1016\/j.dsx.2024.103083_bib72","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbadis.2010.02.008","article-title":"Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants","volume":"1802","author":"Wang","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.dsx.2024.103083_bib73","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/19322968211033868","article-title":"Insulin derived fibrils induce cytotoxicity in vitro and trigger inflammation in murine models","volume":"17","author":"Lewis","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.dsx.2024.103083_bib74","first-page":"388","article-title":"The analysis of the histology, image findings, and insulin absorption about subcutaneous masses which occurred in insulin injection sites","volume":"58","author":"Kusuki","year":"2015","journal-title":"J Japan Diab Soc"},{"issue":"7","key":"10.1016\/j.dsx.2024.103083_bib75","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.xphs.2021.12.025","article-title":"Inflammation at site of insulin infusion diminishes glycemic control","volume":"111","author":"Kesserwan","year":"2022","journal-title":"J Pharmaceut Sci"},{"issue":"16","key":"10.1016\/j.dsx.2024.103083_bib76","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.3390\/ijms23168850","article-title":"Influence of gender in diabetes mellitus and its complication","volume":"23","author":"Ciarambino","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.dsx.2024.103083_bib79","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40265-014-0226-4","article-title":"The evolution of insulin glargine and its continuing contribution to diabetes care","volume":"74","author":"Hilgenfeld","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.dsx.2024.103083_bib80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejps.2014.05.010","article-title":"Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms","volume":"62","author":"Rasmussen","year":"2014","journal-title":"Eur J Pharmaceut Sci"},{"issue":"2","key":"10.1016\/j.dsx.2024.103083_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diacare.5.2.77","article-title":"Absorption kinetics and biologic effects of subcutaneously injected insulin preparations","volume":"5","author":"Berger","year":"1982","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2024.103083_bib82","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1055\/s-0031-1279988","article-title":"Die insulininduzierte, lokale amyloidose der brust-eine seltene differenzialdiagnose zum DCIS und mammakarzinom; amyloid tumor of the breast casued by s.c. injections of insulin - a rare differential diagnosis of DCIS and breast carcinoma","volume":"71","author":"Kayser","year":"2011","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.dsx.2024.103083_bib83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4137\/BMI.S38440","article-title":"Significance of HbA1c test in diagnosis and prognosis of diabetic patients","volume":"11","author":"Sherwani","year":"2016","journal-title":"Biomark Insights"},{"issue":"6","key":"10.1016\/j.dsx.2024.103083_bib84","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/jdi.13753","article-title":"Repeated insulin injection without site rotation affects skin thickness - ultrasonographic and histological evaluation","volume":"13","author":"Murao","year":"2022","journal-title":"J Diabetes Investig."},{"issue":"4","key":"10.1016\/j.dsx.2024.103083_bib85","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/pdi.778","article-title":"Unexpected finding of amyloidosis at the site of insulin injection","volume":"22","author":"Ciin","year":"2005","journal-title":"Practical Diabetes International"},{"issue":"3","key":"10.1016\/j.dsx.2024.103083_bib86","first-page":"138","article-title":"Human recombinant insulin and amyloidosis: an unexpected association","volume":"68","author":"Sie","year":"2010","journal-title":"Neth J Med"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:23:24Z","timestamp":1788434604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402124001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":86,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1871402124001449"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103083","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive investigation of insulin-induced amyloidosis lesions in patients with diabetes at clinical and histological levels: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103083"}}